• OPEN AN ACCOUNT
Indian Indices
Sensex
72,973.68 444.61
( 0.61%)
Global Indices
Nasdaq
51,369.65 -132.86
(-0.26%)
Dow Jones
7,690.99 -13.70
(-0.18%)
Hang Seng
66,863.07 1,381.80
(2.11%)
Nikkei 225
10,628.22 -56.66
(-0.53%)
Forex
USD-INR
95.96 0.17
(0.18%)
EUR-INR
109.15 0.06
(0.06%)
GBP-INR
127.16 0.33
(0.26%)
JPY-INR
0.61 0.00
(0.14%)

EQUITY - MARKET SCREENER

Sun Pharmaceutical Industries Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
524715
INE044A01036
93.2373503
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
SUNPHARMA
140.17
446276.3
EPS(TTM)
Face Value()
Div & Yield %
13.27
1
0.86
 

Frontier Capital reports standalone net profit of Rs 0.08 crore in the June 2026 quarter
Aug 14,2026
Net profit of Frontier Capital remain constant at Rs 0.08 crore in the quarter ended June 2026 and also during the previous quarter ended June 2025. Sales remain constant at Rs 0.09 crore in the quarter ended June 2026 and also during the previous quarter ended June 2025.

ParticularsQuarter Ended
Jun. 2026Jun. 2025% Var.
Sales0.090.09 0
OPM %44.44100.00 -
PBDT0.080.08 0
PBT0.080.08 0
NP0.080.08 0